Ratings and Reviews 0 Ratings

Total 0 out of 5 stars
ease 0 out of 5 stars
features 0 out of 5 stars
design 0 out of 5 stars
support 0 out of 5 stars

This software has no reviews. Be the first to write a review.

Write a Review

Ratings and Reviews 0 Ratings

Total 0 out of 5 stars
ease 0 out of 5 stars
features 0 out of 5 stars
design 0 out of 5 stars
support 0 out of 5 stars

This software has no reviews. Be the first to write a review.

Write a Review

Alternatives to Consider

  • Qualio Reviews & Ratings
    4.4 out of 5 stars 919 Ratings
    Company Website for Qualio
  • Adobe Acrobat Reviews & Ratings
    4.5 out of 5 stars 8,461 Ratings
    Company Website for Adobe Acrobat
  • Lockbox LIMS Reviews & Ratings
    4.8 out of 5 stars 72 Ratings
    Company Website for Lockbox LIMS
  • StackAI Reviews & Ratings
    4.5 out of 5 stars 55 Ratings
    Company Website for StackAI
  • Fraxion Reviews & Ratings
    4.4 out of 5 stars 199 Ratings
    Company Website for Fraxion
  • Interfacing Integrated Management System (IMS) Reviews & Ratings
    4.6 out of 5 stars 66 Ratings
    Company Website for Interfacing Integrated Management System (IMS)
  • Everstage Reviews & Ratings
    4.8 out of 5 stars 3,824 Ratings
    Company Website for Everstage
  • Anaconda Reviews & Ratings
    4.4 out of 5 stars 626 Ratings
    Company Website for Anaconda
  • Jama Connect Reviews & Ratings
    4.3 out of 5 stars 416 Ratings
    Company Website for Jama Connect
  • LeaseAccounting.app Reviews & Ratings
    Company Website for LeaseAccounting.app

What is PubMed?

PubMed® serves as a vast database with over 35 million citations pertaining to biomedical literature, which is derived from MEDLINE, various life science journals, and an array of online books. Numerous citations offer access to full-text articles, which can be found via PubMed Central and the publishers' websites. This critical resource aims to streamline the process of searching and retrieving literature in the biomedical and life sciences sectors, ultimately striving to improve health outcomes on both global and individual scales. While the PubMed platform does not include full-text journal articles directly, it frequently provides hyperlinks to these articles when available from other sources, such as the publisher's website or PubMed Central (PMC). The citations featured in PubMed primarily stem from areas related to biomedicine and health, along with interrelated fields including life sciences, behavioral sciences, chemical sciences, and bioengineering. A considerable portion of PubMed comprises MEDLINE, which includes citations from journals that have been selectively chosen for this collection. Researchers, healthcare professionals, and those interested in medical advancements regularly turn to this platform to remain updated on the newest research findings and developments in the medical field, ensuring they have access to the most relevant information. As such, PubMed stands as an essential tool in the pursuit of improved health knowledge and practices.

What is CoVigilAI?

CoVigilAI represents a state-of-the-art innovation in the realm of medical literature monitoring, harnessing the power of artificial intelligence and advanced data analytics to proactively detect and manage adverse drug reactions, ensuring patient safety and compliance with regulatory requirements in real-time. This platform facilitates the efficient tracking of scientific and medical literature by retrieving data from prominent global databases such as PubMed and Embase, and it offers customizable search options that improve the pharmacovigilance literature review process. Furthermore, it conducts thorough evaluations of scientific articles and publications from various regional journals, guaranteeing an extensive oversight of both global and localized literature. With the implementation of sophisticated algorithms, the system categorizes Individual Case Safety Reports (ICSRs) into three distinct classifications: valid, potential, and invalid cases, while its automated key entity recognition feature proficiently pinpoints critical components such as patients, medications, adverse reactions, and pertinent medical events. This comprehensive strategy not only streamlines the monitoring procedure but also considerably boosts the precision and efficiency of drug safety evaluations, contributing to a safer healthcare environment. Ultimately, CoVigilAI serves as an indispensable tool for enhancing drug safety and fostering informed decision-making in the medical field.

Media

Media

Integrations Supported

AWS Marketplace
Bibliovigilance
CiteDash
CoVigilAI
Cure AI
Noah AI
Rayyan
Resea.AI
Soutron

Integrations Supported

Embase
PubMed

API Availability

Has API

API Availability

Pricing Information

Free
Free Version

Pricing Information

Pricing not provided

Supported Platforms

SaaS

Supported Platforms

SaaS

Customer Service / Support

Web-Based Support

Customer Service / Support

Standard Support
Web-Based Support

Training Options

Documentation Hub
On-Site Training

Training Options

Documentation Hub
Online Training
On-Site Training

Company Facts

Organization Name

PubMed

Date Founded

1996

Company Location

United States

Company Website

pubmed.ncbi.nlm.nih.gov/

Company Facts

Organization Name

CoVigilAI

Company Location

India

Company Website

covigilai.in/

Categories and Features

Academic Research

Not specified

Categories and Features

AI Science

Not specified

Pharmacovigilance

Not specified

Popular Alternatives

Embase Reviews & Ratings

Embase

Elsevier

Popular Alternatives

Ovid Reviews & Ratings

Ovid

Wolters Kluwer
PsycInfo Reviews & Ratings

PsycInfo

American Psychological Association
Dialog Reviews & Ratings

Dialog

Clarivate
MEDLINE Reviews & Ratings

MEDLINE

National Library of Medicine